Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrophic Vaginitis Due to Menopause”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)WithdrawnNCT03740945
What this trial is testing

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Who this might be right for
Vaginal Atrophy in Breast Cancer Patients
EndoCeutics Inc.
Large-scale testing (Phase 3)Study completedNCT01779947
What this trial is testing

Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo

Who this might be right for
Atrophic Vaginitis Due to Menopause
Amneal Pharmaceuticals, LLC 519
Not applicableStudy completedNCT01507454
What this trial is testing

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

Who this might be right for
MenopausePostmenopausal Vaginal Atrophy
Novo Nordisk A/S 1,613

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation